How Republican Billionaires Learned to Love Trump Again
The former President has been fighting to win back his wealthiest donors, while actively courting new ones—what do they expect to get in return?
The former President has been fighting to win back his wealthiest donors, while actively courting new ones—what do they expect to get in return?
Cilta-cel reduced the risk of death by 45% compared with standard of care in patients with multiple myeloma, according to the CARTITUDE-4 study.
In mid-2023, the SWOG S1826 phase 3 trial in advanced Hodgkin lymphoma reported highly positive primary results earlier than expected, after the trial’s second planned…
Amy Selly, CNP, AOCNP, discusses how physicians can support their patients’ survivorship journeys.
The addition of fecal microbiota transplantation to pembrolizumab and axitinib raised the efficacy of the combination in metastatic renal cell carcinoma.
Historically, ovarian cancer (OC) was thought to metastasize by surface-to-surface spread, but recent developments have yielded a new understanding of the paths of metastatic spread.…
Mammograms are the best way to detect breast cancer early. Radiology Dr. Jason Shames breaks down why people over 40 should be screened annually.
Drs Camidge and Zirkelbach discuss Zirkelbach’s first pharmacokinetics forays and her involvement with reforming dose optimization in drug development.
Clinical trials are gateways to a cancer-free world, providing today’s patients with new treatments that could revolutionize care in the future.
Hope S. Rugo, MD, discusses the FDA approval of inavolisib plus palbociclib and fulvestrant in PIK3CA-mutated, HR+/HER2– metastatic breast cancer.